Novavax, Inc. (NVAX)
11.26
-1.56
(-12.17%)
USD |
NASDAQ |
Oct 16, 16:00
11.19
-0.07
(-0.62%)
After-Hours: 20:00
Novavax Cash from Investing (Quarterly) : 34.90M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.90M |
| March 31, 2026 | -28.36M |
| December 31, 2025 | 20.48M |
| September 30, 2025 | -136.53M |
| June 30, 2025 | 111.10M |
| March 31, 2025 | -73.32M |
| December 31, 2024 | 144.01M |
| September 30, 2024 | 31.91M |
| June 30, 2024 | -372.71M |
| March 31, 2024 | -7.25M |
| December 31, 2023 | -9.078M |
| September 30, 2023 | -18.39M |
| June 30, 2023 | -7.779M |
| March 31, 2023 | -23.56M |
| December 31, 2022 | -22.06M |
| September 30, 2022 | -29.52M |
| June 30, 2022 | -24.58M |
| March 31, 2022 | -16.83M |
| December 31, 2021 | -16.36M |
| September 30, 2021 | -12.19M |
| June 30, 2021 | -12.90M |
| March 31, 2021 | 141.61M |
| December 31, 2020 | -31.12M |
| September 30, 2020 | -100.71M |
| June 30, 2020 | -188.22M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.73M |
| December 31, 2019 | -0.216M |
| September 30, 2019 | 17.97M |
| June 30, 2019 | 2.024M |
| March 31, 2019 | 18.71M |
| December 31, 2018 | 48.32M |
| September 30, 2018 | 7.996M |
| June 30, 2018 | -48.30M |
| March 31, 2018 | 20.59M |
| December 31, 2017 | 16.76M |
| September 30, 2017 | 41.96M |
| June 30, 2017 | 2.531M |
| March 31, 2017 | -25.28M |
| December 31, 2016 | 85.90M |
| September 30, 2016 | 92.57M |
| June 30, 2016 | 18.98M |
| March 31, 2016 | -169.44M |
| December 31, 2015 | 9.559M |
| September 30, 2015 | -9.21M |
| June 30, 2015 | -39.41M |
| March 31, 2015 | 17.79M |
| December 31, 2014 | 17.35M |
| September 30, 2014 | -54.10M |
| June 30, 2014 | -102.78M |
| March 31, 2014 | 9.701M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | 329.00M |
| Merck & Co., Inc. | -5.602B |
| Pfizer Inc. | 2.106B |
| Amgen, Inc. | -569.00M |
| Editas Medicine, Inc. | -29.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -72.81M |
| Cash from Financing (Quarterly) | 1.201M |
| Free Cash Flow | -43.02M |
| Free Cash Flow Per Share (Quarterly) | -0.446 |
| Free Cash Flow to Equity (Quarterly) | -75.66M |
| Free Cash Flow to Firm (Quarterly) | -67.52M |
| Free Cash Flow Yield | -2.33% |